Cargando…
Effect of Praziquantel on Schistosoma mekongi Proteome and Phosphoproteome
Schistosoma mekongi causes schistosomiasis in southeast Asia, against which praziquantel (PZQ) is the only treatment option. PZQ resistance has been reported, thus increasing the requirement to understand mechanism of PZQ. Herein, this study aimed to assess differences in proteome and phosphoproteom...
Autores principales: | Chienwichai, Peerut, Ampawong, Sumate, Adisakwattana, Poom, Thiangtrongjit, Tipparat, Limpanont, Yanin, Chusongsang, Phiraphol, Chusongsang, Yupa, Reamtong, Onrapak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350297/ https://www.ncbi.nlm.nih.gov/pubmed/32471184 http://dx.doi.org/10.3390/pathogens9060417 |
Ejemplares similares
-
Phosphoproteomics analysis of male and female Schistosoma mekongi adult worms
por: Simanon, Nattapon, et al.
Publicado: (2019) -
Metabolomics reveal alterations in arachidonic acid metabolism in Schistosoma mekongi after exposure to praziquantel
por: Chienwichai, Peerut, et al.
Publicado: (2021) -
Discovery of Schistosoma mekongi circulating proteins and antigens in infected mouse sera
por: Uthailak, Naphatsamon, et al.
Publicado: (2022) -
Identification of Low Molecular Weight Proteins and Peptides from Schistosoma mekongi Worm, Egg and Infected Mouse Sera
por: Thiangtrongjit, Tipparat, et al.
Publicado: (2021) -
Untargeted serum metabolomic profiling for early detection of Schistosoma mekongi infection in mouse model
por: Chienwichai, Peerut, et al.
Publicado: (2022)